AstraZeneca-CICC healthcare investment fund Investment Portfolio
AstraZeneca-CICC Healthcare Investment Fund is a joint investment vehicle formed by AstraZeneca and China International Capital Corporation (CICC). The fund makes strategic investments in Chinese healthcare and life sciences companies, targeting innovation across pharmaceuticals, biotechnology and related healthcare services.Healthcare, Biotechnology & Medical Devices
$45.00M
Series B